| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/18/2005 | US6844185 Integrated biomolecule sensor, method and apparatus for fabricating the sensor, and method and apparatus for detecting biomolecules using the sensor |
| 01/18/2005 | US6844180 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 01/18/2005 | US6844179 Protein and DNA thereof |
| 01/18/2005 | US6844175 Methods of inhibition using glycosyl sulfotransferase-3 |
| 01/18/2005 | US6844171 Oligomerization of hepatitis delta antigen |
| 01/18/2005 | US6844165 For diagnosis, drug discovery; both parallel and muliplex analyte processing capabilities; retentate chromatography is a combinatorial method to provide high information resolution of analytes in complex mixtures |
| 01/18/2005 | US6844160 Nucleotide sequences for detection of Bacillus anthracis |
| 01/18/2005 | US6844159 Genetic markers for screening animals for improved disease resistance (NRAMP) |
| 01/18/2005 | US6844158 Using immobilized nucleotide sequences and reverse transcription-polymerase chain reaction (RT-PCR) to analyze gene expression; drug screening |
| 01/18/2005 | US6844157 Detection of microorganism in sample; obtain sample containing microorganism, extract nucleotide sequence, incubate with probe, detect hybridization pattern and compare to control containing microorganism |
| 01/18/2005 | US6844156 Accurately detecting preferential liver graft doner; obtain human tissue sample, determine genotype, the presence of preferred genotype indicates potential liver graft doner |
| 01/18/2005 | US6844155 Monitoring polymerase chain reaction sample for impurities; amplfy nucleotide sequences, screen sample for impurities |
| 01/18/2005 | US6844154 High throughput methods for haplotyping |
| 01/18/2005 | US6844153 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 01/18/2005 | US6844152 Detection of microsatellite instability and its use in diagnosis of tumors |
| 01/18/2005 | US6844151 The modified associated nucleic acids of the array produced exhibit substantial resistance to nuclease degradation |
| 01/18/2005 | US6844148 Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| 01/18/2005 | US6844000 A purified Parapoxvirus ovis envelope protein termed "B2L" can be used as a monotherapeutic agent. B2L protein also can be used in screening methods to identify potential therapeutic agents for modulating a subject's immune response |
| 01/18/2005 | CA2188660C Detection of mutation by resolvase cleavage |
| 01/18/2005 | CA2169603C Retrovirus from the hiv group and its use |
| 01/18/2005 | CA2124207C Culture media device |
| 01/18/2005 | CA2074556C Immunological detection method |
| 01/17/2005 | CA2475163A1 Use of lipase for high-density lipoprotein cholesterol detection |
| 01/17/2005 | CA2474952A1 A one-step assay for high-density lipoprotein cholesterol |
| 01/17/2005 | CA2474843A1 Dry analytical element for high-density lipoprotein cholesterol quantification |
| 01/13/2005 | WO2005004204A2 An electrochemical method and resulting structures for attaching molecular and biomolecular structures to semiconductor micro and nanostructures |
| 01/13/2005 | WO2005003821A2 Phase change sensor |
| 01/13/2005 | WO2005003787A1 Particle agglutination detection method and device |
| 01/13/2005 | WO2005003783A1 Methods for identifying compounds interacting with small membrane-bound gtp-ases |
| 01/13/2005 | WO2005003778A2 A method for identifying a synthetic molecule having affinity towards a target |
| 01/13/2005 | WO2005003776A2 In vitro methods for detecting renal cancer |
| 01/13/2005 | WO2005003770A1 Biochemical reaction system, biochemical reaction substrate, process for producing hybridization substrate and hybridization method |
| 01/13/2005 | WO2005003766A2 Methods of regulating metabolism and mitochondrial function |
| 01/13/2005 | WO2005003765A1 Isothermal titration calorimetry assays |
| 01/13/2005 | WO2005003750A1 Pyrophosphoric acid detection sensor, method of detecting nucleic acid and method of discriminating base variety |
| 01/13/2005 | WO2005003743A2 Apparatus and methods for surface plasmon-coupled directional emission |
| 01/13/2005 | WO2005003721A2 Enzyme activity assays on protein microarrays |
| 01/13/2005 | WO2005003395A1 Method for amplifying and detecting nucleic acids in microfluidic devices under continuous and non-continuous flow conditions |
| 01/13/2005 | WO2005003394A2 Bio-barcode based detection of target analytes |
| 01/13/2005 | WO2005003393A2 Splice site aflp |
| 01/13/2005 | WO2005003392A2 Hmg coenzyme a reductase inhibitors affect the mitochondrial dna content of cells |
| 01/13/2005 | WO2005003391A1 Cucurbituril derivative-bonded solid substrate and biochip using the same |
| 01/13/2005 | WO2005003390A2 Method for detection of mutations in dna |
| 01/13/2005 | WO2005003389A2 In vitro amplification of dna |
| 01/13/2005 | WO2005003388A2 Fluorescence assays for nucleic acid polymerase activity |
| 01/13/2005 | WO2005003387A2 Specific method of prostate cancer detection based on pca3 gene, and kits therefor |
| 01/13/2005 | WO2005003386A2 Oligonucleotide ligation assay by detecting released pyrophosphate |
| 01/13/2005 | WO2005003385A1 Method for detecting nucleic acids with internal control of the amplification |
| 01/13/2005 | WO2005003384A1 Method for selective detection of a target nucleic acid |
| 01/13/2005 | WO2005003383A1 Improvements in sensor chips |
| 01/13/2005 | WO2005003382A1 Mutation associated with strokes |
| 01/13/2005 | WO2005003381A1 Method for detection of alkylated cytosine in dna |
| 01/13/2005 | WO2005003380A1 Methods for detecting aneuploidy using microparticle multiplex detection |
| 01/13/2005 | WO2005003378A2 Methods for analyzing transcripts |
| 01/13/2005 | WO2005003377A2 Method for monitoring reactions in real time |
| 01/13/2005 | WO2005003376A2 Anthrax antigen vaccine cultures by fluorescence polarization |
| 01/13/2005 | WO2005003375A2 Methods of amplifying and sequencing nucleic acids |
| 01/13/2005 | WO2005003373A2 Fluorogenic nucleic acid probes including lna for methods to detect and/or quantify nucleic acid analytes |
| 01/13/2005 | WO2005003371A2 Erk7 and erk8, novel diagnostic markers for cancer |
| 01/13/2005 | WO2005003370A2 Methods for enhancing gene expression analysis |
| 01/13/2005 | WO2005003358A1 Inhibition of calcitriol mediated cyp24 induction screening for compounds therefore and uses thereof |
| 01/13/2005 | WO2005003355A1 Method for the identification of fungicidal compounds based on mevalonate kinases as fungi |
| 01/13/2005 | WO2005003352A1 Method of judging responsivenesses to taxans |
| 01/13/2005 | WO2005003336A2 Newly identified cholinephosphotransferases and ethanolaminephosphotransferases |
| 01/13/2005 | WO2005003326A2 Artificial receptors including reversibly immobilized building blocks and methods |
| 01/13/2005 | WO2005003318A2 Assay and process for labeling and detection of micro rna and small interfering rna sequences |
| 01/13/2005 | WO2005003316A2 Rna processing protein complexes and uses thereof |
| 01/13/2005 | WO2005003315A2 Compositions and methods for peptide-assisted transfection |
| 01/13/2005 | WO2005003314A2 A method of selecting an active oligonucleotide predictive model |
| 01/13/2005 | WO2005003305A2 Usps as modifiers of the beta catenin pathway and methods of use |
| 01/13/2005 | WO2005003304A2 Methods and compositions for whole genome amplification and genotyping |
| 01/13/2005 | WO2005003301A2 Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms |
| 01/13/2005 | WO2005003299A2 Polynucleotides encoding novel guanylate binding proteins (gbp's) |
| 01/13/2005 | WO2005003297A2 Mptens as modifiers of the pten/igf pathway and methods of use |
| 01/13/2005 | WO2005003293A2 pRNA CHIMERA |
| 01/13/2005 | WO2005003291A2 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 01/13/2005 | WO2005003290A2 Methods and devices for determining a cell characteristic, and applications employing same |
| 01/13/2005 | WO2005003289A2 Ap1 amine oxidase variants |
| 01/13/2005 | WO2005003288A2 Diagnostic methods , prognostic methods and pharmaceutical compositions for neurodegenerative diseases like alzheimer’s disease by modulating and investigating genes rgs4 and itpkb, their gene products or fragments and derivatives thereof |
| 01/13/2005 | WO2005003159A1 Complement depletion using recombinant human c3-derivatives |
| 01/13/2005 | WO2005003158A2 Compositions and methods for increasing bone mineralization |
| 01/13/2005 | WO2005003154A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2005 | WO2005002527A2 Sirt1 modulation of adipogenesis and adipose function |
| 01/13/2005 | WO2005002521A2 Methods for the identification of inhibitors of acetolactate synthase and potassium transport protein as antibiotics |
| 01/13/2005 | WO2005002505A2 Apolipoprotein c-1 induced apoptosis |
| 01/13/2005 | WO2005002502A2 An assay for detecting the presence of processing inhibitory antibodies against the apical membrane antigene-1 of plasmodium falciparum in biological samples |
| 01/13/2005 | WO2005002501A2 Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same |
| 01/13/2005 | WO2005002419A2 Diagnosis of kabuki syndrome |
| 01/13/2005 | WO2005002418A2 Mptens as modifiers of the pten/igf pathway and methods of use |
| 01/13/2005 | WO2005002417A2 Cancer -linked gene aas target for chemotherapy |
| 01/13/2005 | WO2005002416A2 Predictors of renal disease |
| 01/13/2005 | WO2005002414A2 Prognosis determination in ewing sarcoma patients by means of genetic profiling |
| 01/13/2005 | WO2005002324A2 Method of producing double low restorer lines of brassica napus having a good agronomic value |
| 01/13/2005 | WO2004100986A3 Pharmaceutical use of an adam 10 inhibitory substance |
| 01/13/2005 | WO2004100229A3 Biocompatible sensor electrode assembly and method for the production thereof |
| 01/13/2005 | WO2004094658A3 Fluorescent substrates for detecting organophosphatase enzyme activity |
| 01/13/2005 | WO2004082568A3 Diagnostics and therapeutics for diseases associated with complement component 5a receptor (c5ar) |
| 01/13/2005 | WO2004078943A3 Alternative heterocycles for dna recognition |
| 01/13/2005 | WO2004074815A3 Predicting graft rejection |
| 01/13/2005 | WO2004074807A3 Assay for the identification of protein sic inhibitor |